Report Summary
Eternity Insights has published a new study on Global Diabetic Lancing Device Market focusing on key segments as by Type (Push Button Safety Lancets, Pressure Activated Safety Lancets, Side Button Safety Lancets, Other), by Application (Hospitals, Clinics, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Diabetic Lancing Device Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Diabetic Lancing Device Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Diabetic Lancing Device Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Diabetic Lancing Device Market Segmentation:
Diabetic Lancing Device Market, By Type
- Push Button Safety Lancets
- Pressure Activated Safety Lancets
- Side Button Safety Lancets
- Other
Diabetic Lancing Device Market, By Application
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Diabetic Lancing Device market in terms of demand generation. The Diabetic Lancing Device market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Diabetic Lancing Device market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Diabetic Lancing Device Market Taxonomy:
To learn more about this report
Global Diabetic Lancing Device Market Competitive Landscape
The global Diabetic Lancing Device market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- B. Braun
- Terumo Corporation
- Becton Dickinson
- Sanofi
- Roche
- Bayer
- Novo Nordisk
- Eli Lilly
- Medtronic
- Ypsomed Holding
- Sarstedt
- Abbott Laboratories
- HTL-STREFA
- Improve Medical
- UltiMed
- Allison Medical
- Artsana
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Push Button Safety Lancets, Pressure Activated Safety Lancets, Side Button Safety Lancets, Other |
| By Application Outlook |
Hospitals, Clinics, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
B. Braun, Terumo Corporation, Becton Dickinson, Sanofi, Roche, Bayer, Novo Nordisk, Eli Lilly, Medtronic, Ypsomed Holding, Sarstedt, Abbott Laboratories, HTL-STREFA, Improve Medical, UltiMed, Allison Medical, Artsana |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Diabetic Lancing Device Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Diabetic Lancing Device Market Size Growth Rate by Product
1.4.2 Push Button Safety Lancets
1.4.3 Pressure Activated Safety Lancets
1.4.4 Side Button Safety Lancets
1.5 Market by End User
1.5.1 Global Diabetic Lancing Device Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diabetic Lancing Device Market Size
2.1.1 Global Diabetic Lancing Device Revenue 2014-2025
2.1.2 Global Diabetic Lancing Device Sales 2014-2025
2.2 Diabetic Lancing Device Growth Rate by Regions
2.2.1 Global Diabetic Lancing Device Sales by Regions
2.2.2 Global Diabetic Lancing Device Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Diabetic Lancing Device Sales by Manufacturers
3.1.1 Diabetic Lancing Device Sales by Manufacturers
3.1.2 Diabetic Lancing Device Sales Market Share by Manufacturers
3.1.3 Global Diabetic Lancing Device Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Lancing Device Revenue by Manufacturers
3.2.1 Diabetic Lancing Device Revenue by Manufacturers (2017-2020)
3.2.2 Diabetic Lancing Device Revenue Share by Manufacturers (2017-2020)
3.3 Diabetic Lancing Device Price by Manufacturers
3.4 Diabetic Lancing Device Manufacturing Base Distribution, Product Types
3.4.1 Diabetic Lancing Device Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diabetic Lancing Device Product Type
3.4.3 Date of International Manufacturers Enter into Diabetic Lancing Device Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Diabetic Lancing Device Sales by Product
4.2 Global Diabetic Lancing Device Revenue by Product
4.3 Diabetic Lancing Device Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Diabetic Lancing Device Breakdown Data by End User
6 North America
6.1 North America Diabetic Lancing Device by Countries
6.1.1 North America Diabetic Lancing Device Sales by Countries
6.1.2 North America Diabetic Lancing Device Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Diabetic Lancing Device by Product
6.3 North America Diabetic Lancing Device by End User
7 Europe
7.1 Europe Diabetic Lancing Device by Countries
7.1.1 Europe Diabetic Lancing Device Sales by Countries
7.1.2 Europe Diabetic Lancing Device Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diabetic Lancing Device by Product
7.3 Europe Diabetic Lancing Device by End User
8 Asia Pacific
8.1 Asia Pacific Diabetic Lancing Device by Countries
8.1.1 Asia Pacific Diabetic Lancing Device Sales by Countries
8.1.2 Asia Pacific Diabetic Lancing Device Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Diabetic Lancing Device by Product
8.3 Asia Pacific Diabetic Lancing Device by End User
9 Central & South America
9.1 Central & South America Diabetic Lancing Device by Countries
9.1.1 Central & South America Diabetic Lancing Device Sales by Countries
9.1.2 Central & South America Diabetic Lancing Device Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Diabetic Lancing Device by Product
9.3 Central & South America Diabetic Lancing Device by End User
10 Middle East and Africa
10.1 Middle East and Africa Diabetic Lancing Device by Countries
10.1.1 Middle East and Africa Diabetic Lancing Device Sales by Countries
10.1.2 Middle East and Africa Diabetic Lancing Device Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Diabetic Lancing Device by Product
10.3 Middle East and Africa Diabetic Lancing Device by End User
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Company Details
11.1.2 Company Business Overview
11.1.3 B. Braun Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.1.4 B. Braun Diabetic Lancing Device Products Offered
11.1.5 B. Braun Recent Development
11.2 Terumo Corporation
11.2.1 Terumo Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Terumo Corporation Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Terumo Corporation Diabetic Lancing Device Products Offered
11.2.5 Terumo Corporation Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Company Business Overview
11.3.3 Becton Dickinson Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Becton Dickinson Diabetic Lancing Device Products Offered
11.3.5 Becton Dickinson Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Sanofi Diabetic Lancing Device Products Offered
11.4.5 Sanofi Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Company Business Overview
11.5.3 Roche Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Roche Diabetic Lancing Device Products Offered
11.5.5 Roche Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Company Business Overview
11.6.3 Bayer Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Bayer Diabetic Lancing Device Products Offered
11.6.5 Bayer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Company Business Overview
11.7.3 Novo Nordisk Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Novo Nordisk Diabetic Lancing Device Products Offered
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Eli Lilly Diabetic Lancing Device Products Offered
11.8.5 Eli Lilly Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Company Business Overview
11.9.3 Medtronic Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Medtronic Diabetic Lancing Device Products Offered
11.9.5 Medtronic Recent Development
11.10 Ypsomed Holding
11.10.1 Ypsomed Holding Company Details
11.10.2 Company Business Overview
11.10.3 Ypsomed Holding Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Ypsomed Holding Diabetic Lancing Device Products Offered
11.10.5 Ypsomed Holding Recent Development
11.11 Sarstedt
11.12 Abbott Laboratories
11.13 HTL-STREFA
11.14 Improve Medical
11.15 UltiMed
11.16 Allison Medical
11.17 Artsana
12 Future Forecast
12.1 Diabetic Lancing Device Market Forecast by Regions
12.1.1 Global Diabetic Lancing Device Sales Forecast by Regions 2021-2027
12.1.2 Global Diabetic Lancing Device Revenue Forecast by Regions 2021-2027
12.2 Diabetic Lancing Device Market Forecast by Product
12.2.1 Global Diabetic Lancing Device Sales Forecast by Product 2021-2027
12.2.2 Global Diabetic Lancing Device Revenue Forecast by Product 2021-2027
12.3 Diabetic Lancing Device Market Forecast by End User
12.4 North America Diabetic Lancing Device Forecast
12.5 Europe Diabetic Lancing Device Forecast
12.6 Asia Pacific Diabetic Lancing Device Forecast
12.7 Central & South America Diabetic Lancing Device Forecast
12.8 Middle East and Africa Diabetic Lancing Device Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diabetic Lancing Device Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
